Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: A randomized controlled trial

Indian Pediatrics

Volumn 44, Issue 11, 2007, Pages 817-822

  Chawla, D ^a   Deorari, A K ^a   Saxena, R ^a   Paul, V K ^a   Agarwal, R ^a   Biswas, A ^a   Meena, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hemorrhagic disease of newborn; Prophylaxis; Vitamin K

Indexed keywords

ACETOMENAPHTHONE; BIOLOGICAL MARKER; KENADION; MENADIONE; PHYTOMENADIONE; UNCLASSIFIED DRUG; DECARBOXYPROTHROMBIN; PROTEIN PRECURSOR; PROTHROMBIN; VITAMIN;

ANTICOAGULANT THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; CHILD CARE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; OUTCOME ASSESSMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TREATMENT PLANNING; VITAMIN DEFICIENCY; BLOOD; COMPARATIVE STUDY; VITAMIN K DEFICIENCY;

BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; PROTEIN PRECURSORS; PROTHROMBIN; VITAMIN K 1; VITAMIN K 3; VITAMIN K DEFICIENCY; VITAMINS;

EID: 36448983240     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1 concentration and vitamin K-dependent clotting factor activity in maternal and fetal cord blood. Am J Obstet Gynecol 1985; 153: 771-774.
2. Greer FR. Vitamin K status of lactating mothers and their infants. Acta Pediatr Suppl 1999; 88: 95-103.
3. Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics 2003; 112: 191-192.
4. Joint Statement and Interim Recommendations on Vitamin K Prophylaxis for Hemorrhagic Disease in Infancy. National Health and Medical Research Council. The Australian College of Pediatrics and the Royal Australian College of Obstetricians and Gynecologists. J Pediatr Child Health 1993; 29: 182.
5. The use of vitamin K in the perinatal period. Fetus and Newborn Committee, Canadian Paediatric Society. Cmaj CMAJ 1988; 139: 127-130.
6. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev 2000: CD002776.
7. Admiral J, Grosley M, Plassart V, Mimilla F, Chambrette B. Development of a monoclonal immunoassay for the direct measurement of descarboxyprothrombin of plasma (abstract). Thromb Hemost 1991; 65: 648.
8. Sharma RK, Marwaha N, Kumar P, Narang A. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns. Indian Pediatr 1995; 32: 863-867.
9. Bakhshi S, Deorari AK, Roy S, Paul VK, Singh M. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route. Indian Pediatr 1996; 33: 1040-1043.
10. von Kries R, Kreppel S, Becker A, Tangermann R, Gobel U. Acarboxyprothrombin concentration (corrected) after oral prophylactic vitamin K. Arch Dis Child 1987; 62: 938-940.
11. Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985; 2: 242-244.
12. Greer FR, Marshall SP, Severson RR, Smith DA, Shearer MJ, Pace DG, et al. A new mixed micellar preparation for oral vitamin K prophylaxis: randomized controlled comparison with an intramuscular formulation in breast fed infants. Arch Dis Child 1998; 79: 300-305.
13. Lee SC, Ng SS, Oldenburg J, Chong PY, Rost S, Guo JY, et al. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clin Pharmacol Ther 2006; 79: 197-205.